The Virtual Press Room is a courtesy for corporate and institutional public relations professionals. Publication of material on this page does not constitute an endorsement by ASCO of any product or claim.
For information about how to submit a press release to the Virtual Press Room, visit the For PR Professionals page.
2015 Gastrointestinal Cancers Symposium
GenSpera Announces Positive Phase II Data for Investigational Agent Mipsagargin
In IMAGE 1, a randomised controlled Phase II clinical trial, administration of IMM 101 with gemcitabine demonstrates significant survival advantage over gemcitabine alone
Ipsen Biopharmaceuticals To Present Further Data on Recently FDA-Approved Antitumor Therapy, Somatuline® Depot® (lanreotide), at Gastrointestinal Cancers Symposium
The Ohio State University Comprehensive Cancer Center
Modified Pancreatic-Cancer Regimen Maintains Effectiveness While Reducing Side Effects and Cost